About Uvic Steratics
Uvic Steratics is a company based in Seoul (South Korea) founded in 2018. Uvic Steratics has raised $17.6 million across 1 funding round from investors including Korean Development Bank, Atinum Investment and Solidus Investment. Uvic Steratics operates in a competitive market with competitors including Accutar Biotechnology, Plexium, Photys Therapeutics, Lycia Therapeutics and Outruntx, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Ubic Therapeutics Co., Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.6 M (USD)
in 1 rounds
-
Latest Funding Round
$17.6 M (USD), Series B
Dec 24, 2024
-
Investors
Korean Development Bank
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Uvic Steratics
Uvic Steratics has successfully raised a total of $17.6M through 1 strategic funding round. The most recent funding activity was a Series B round of $17.6 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Uvic Steratics
Uvic Steratics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Korean Development Bank, Atinum Investment and Solidus Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
A global venture platform focused on biotech and healthcare startups is operated.
|
Locked | Locked | Locked | |
|
VC firm investing in geographies such as South Korea
|
Locked | Locked | Locked |
Investor details for Uvic Steratics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Uvic Steratics
Investment portfolio details for Uvic Steratics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Uvic Steratics
Detailed financials for Uvic Steratics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Uvic Steratics Comparisons
Peer comparison for Uvic Steratics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Uvic Steratics
Uvic Steratics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accutar Biotechnology, Plexium, Photys Therapeutics, Lycia Therapeutics and Outruntx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-assisted tools for drug discovery are developed.
|
|
| Locked | Locked | Locked |
Integrated chemistry service provider
|
|
| Locked | Locked | Locked |
Protein-based small molecules are developed to treat human diseases.
|
|
| Locked | Locked | Locked |
Protein degradation drugs are developed for cancer and autoimmune diseases.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for cancer treatment
|
Detailed competitors of Uvic Steratics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Uvic Steratics
Complete news archive for Uvic Steratics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Uvic Steratics
Uvic Steratics was founded in 2018 and raised its 1st funding round 6 years after it was founded.
Uvic Steratics is headquartered in Seoul, South Korea.
Servo Optical is the current CEO of Uvic Steratics.
Uvic Steratics is a funded company, having raised a total of $17.6M across 1 funding round to date.
Founded in 2018 and based in Seoul, South Korea, Uvic Steratics operates in the biotechnology sector. Anti-cancer drugs are developed using an inhibitor technology that targets disease-related proteins for degradation. This approach involves binding the proteins near E3 ligases to activate the cellular proteolysis system, aiming for therapeutic effects through protein breakdown. Operations focus on advancing this chimera-based method for oncology applications.
Uvic Steratics's top competitors include Plexium, Photys Therapeutics and Accutar Biotechnology.
Uvic Steratics has 6 investors. Key investors include Korean Development Bank, Atinum Investment, Solidus Investment, Shinyoung Asset Management, and Mint Venture Partners.